0.4132USD-77.90%Mkt Cap: 557414 $P/E: —2d ago
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of sol…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap557.41K $
Enterprise Value-247.94K $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-11.91M $
Revenue/Share—
Last Price0.4132 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.62
PEG—
EV/EBITDA0.02
EV/Revenue—
P/S—
P/B0.47
EPS (TTM)-19.89
EPS (Forward)-0.64
52W Range
0.39450% of range85.90
52W High85.90 USD
52W Low0.3945 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-457.63%
ROA-165.10%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.82M $
CapEx (TTM)9.00K $
FCF Margin—
FCF Yield-1343.91%
Net Debt-424.00K $
Net Debt/EBITDA0.03
Balance Sheet
Debt/Equity0.78
Current Ratio1.00
Quick Ratio0.59
Book Value/Sh0.8570 USD
Cash/Share5.759 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMay 29, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)60.00 USD
Upside (mean)+14420.8%
Target Range60.00 USD – 60.00 USD
# Analysts1
Ownership
Shares Out.5.56M
Float414.62K
Insiders7.61%
Institutions0.96%
Short Interest
Short Ratio0.3d
Short % Float2.41%
Short % Out.2.00%
Shares Short21.28K
Short (prev mo.)13.74K
Technical
SMA 502.162 (-80.9%)
SMA 20013.00 (-96.8%)
Beta-0.27
S&P 52W Chg18.16%
Avg Vol (30d)93.64K
Avg Vol (10d)1.02M
Technical Indicators
RSI (14)20.4
MACD-0.4381
MACD Signal-0.3628
MACD Hist.-0.0753
BB Upper3.219 USD
BB Middle2.137 USD
BB Lower1.054 USD
BB Width101.35%
ATR (14)0.3721 USD
Vol Ratio (20d)2.54x